This item requires a subscription to Diabetes Care.
Full Text (PDF)
Original Research - Emerging Treatments & Technologies:
Bernard Zinman,
John Gerich,
John B. Buse,
Andrew Lewin,
Sherwyn Schwartz,
Philip Raskin,
Paula M. Hale,
Milan Zdravkovic,
Lawrence Blonde,
and the LEAD-4 Study Investigators
Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione
in Patients With Type 2 Diabetes (LEAD-4 Met+TZD) Diabetes Care July 2009 32:1224-1230; published ahead of print March 16, 2009, doi:10.2337/dc08-2124